Background Transcatheter aortic valve replacement (TAVR) is routinely used in patients with
severe aortic stenosis at increased operative risk. Due to potential technical difficulties …

In recent years, the phenomenon of subclinical leaflet thrombosis (SLT) in patients who have
undergone transcatheter aortic valve implantation has become increasingly relevant. Hypo …

Transcatheter aortic valve implantation has become an established procedure to treat
severe aortic stenosis. Correct device sizing/positioning is crucial for optimal outcome. Lotus …

Background Transfemoral transcatheter aortic valve replacement (TF‐TAVR) is
recommended for patients suffering from aortic valve stenosis at increased operative risk …

Abstract Background The recent PARTNER S3i trial compared transcatheter aortic valve
implantation (TAVI) using the third-generation SAPIEN 3 device to surgical aortic valve …

Aims: In patients with aortic stenosis randomised to transcatheter aortic valve implantation
(TAVI) or surgical aortic valve replacement (SAVR), sex-specific differences in complication …

Transcatheter aortic valve implantation (TAVI) performed using femoral arterial access is
now a guideline recommended treatment for severe calcific aortic stenosis (AS) in elderly …

Transcatheter aortic valve implantation (TAVI) has emerged as the gold standard technique
for all patients with symptomatic severe aortic stenosis at elevated surgical risk. Much …

Background Limited data suggest that transcatheter (TAVR) as compared with surgical aortic
valve replacement (SAVR) may be more effective in female than male patients. To date …

Aims There is an increasing awareness of gender-related differences in patients with severe
aortic stenosis and their outcomes after surgical aortic valve replacement (SAVR) and …